ArticleInternational urogynecology journal2025
Multiplex Polymerase Chain Reaction vs Standard Urine Culture in Women Presenting with Symptoms of Acute Cystitis.
Article in International urogynecology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisPrior studies suggest that acute cystitis diagnosis using standard urine culture (SUC) may be suboptimal compared to multiplex polymerase chain reaction (mPCR). mPCR is hypothesized to deliver faster and more accurate results.
methodsThis was a prospective, paired, within-subject study of female patients ≥ 60 years presenting with symptoms of acute cystitis. For all patients, urine samples were collected and SUC and mPCR results using the Vikor Urine-ID™ platform were obtained. Initial treatment was based on the results of the first available test, either SUC or mPCR. The primary outcome was time from initial presentation to correct antibiotic therapy. Secondary outcomes included patient perception of symptoms, antibiotic regimen changes, and discordance between the test results.
resultsA total of 87 patients were eligible for analysis. Overall, there were 36 positive SUC (41.4%) and 71 positive mPCR (81.6%) results. Discordant results were noted in 43.7% of patients, which lead to treatment changes in 33.3% of patients. The time to correct antibiotic therapy was not significantly different based on initial treatment choice test (mPCR 67.0 h vs SUC 78.2 h, p = 0.16). However, in the case of positive SUC, the time to correct antibiotic therapy was significantly shorter for mPCR (mPCR 64.8 h vs SUC 79.5 h, p = 0.02). Non-Escherichia coli species, specifically Enterococcus faecalis, were more likely to be identified on mPCR (43.7%) than on SUC (8.3%), p < 0.001.
conclusionsmPCR may be an effective method of identifying urinary pathogens in symptomatic patients, particularly those with non-Escherichia coli species.
Indexed as
Identifiers
40911199What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.